CVS vs TOI
CVS: A leading health solutions company integrating retail pharmacy, pharmacy benefit management, and insurance services to manage health costs and improve access to care. TOI: The Oncology Institute is a value-based oncology care provider that manages outpatient cancer treatment through a national network of clinics and integrated specialty pharmacies.
Side-by-side fundamentals
| Metric | CVS | TOI | Edge |
|---|---|---|---|
| Price as of 2026-08-05 close | $99.12 | $5.17 | |
| Market cap as of 2026-08-06 | $126.5B | $517M | |
| P/E as of 2026-08-06 | 42.57 | n/a | |
| PEG as of 2026-08-06 | 3.30 | n/a | |
| Net margin as of 2026-08-06 | +0.7% | -8.0% | CVS higher |
| Gross margin as of 2026-08-06 | +13.9% | +15.1% | TOI higher |
| Operating margin as of 2026-08-06 | +1.6% | -6.0% | CVS higher |
| ROE as of 2026-08-06 | +3.9% | -482.6% | CVS higher |
| ROA as of 2026-08-06 | +1.1% | -26.5% | CVS higher |
| Debt / equity as of 2026-08-06 | 0.81 | 14.58 | CVS lower |
| Revenue growth (YoY) as of 2026-08-06 | +7.6% | +35.4% | TOI higher |
| Revenue CAGR (3y) SEC XBRL | +7.6% | +25.8% | TOI higher |
| Dividend yield as of 2026-08-06 | +2.5% | n/a | |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-08-06 | 0.58 | 0.34 | |
| 1-year return as of 2026-08-05 close | +56.3% | +28.3% | CVS higher |
Fundamentals: market data, as of 2026-08-06. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-05.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.